RxDoctor Payments DataLook up a doctor →

Abby Beedy, PA

Medical · Maryville, ILNPI 1942497037

Payments from drug & device makers

$7,937in general payments, 2019–2025

Across 434 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$409
  • GSK$346
  • Optinose US, Inc.$252
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$7,88799%
  • Education$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,937 in reported general payments places this provider in the 90th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois

Medicare billing

Part B allowed, 2024
$36,910
Medicare patients
179
Services billed
1,067

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$93,493
MounjaroTirzepatide63$67,774
EliquisApixaban84$56,796
FarxigaDapagliflozin Propanediol44$55,852
TrulicityDulaglutide25$39,566
JardianceEmpagliflozin41$37,634
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$26,987
GemtesaVibegron19$14,691
MyrbetriqMirabegron12$12,625
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,002
XareltoRivaroxaban19$10,725
LinzessLinaclotide15$8,091
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen110$3,751
Icosapent Ethyl14$3,552
Janumet XrSitagliptin Phos/Metformin Hcl12$3,493

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,191$107,34088 claims
Novo NordiskOzempic$409$93,49381 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,854$66,85461 claims
PfizerEliquis, Dilantin$198$57,70196 claims
Boehringer IngelheimJardiance$83$37,63441 claims
GSKTrelegy Ellipta$346$26,98727 claims
Sumitomo Pharma America, Inc.Gemtesa$132$14,69119 claims
Astellas Pharma US IncMyrbetriq$14$12,62512 claims
Johnson & JohnsonXarelto$162$10,72519 claims
AbbVieLinzess, Synthroid$1,601$9,01929 claims
MerckJanumet Xr$56$3,49312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 449 medical providers in Illinois.

Other medical in Maryville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →